20th Annual Women and Ischemic Heart Disease Symposium

Friday, April 17, 2026, 7:30 AM - 2:15 PM PT, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA


The 20th Annual Women and Ischemic Heart Disease Symposium will explore sex- and diversity-specific issues in womens cardiovascular health, featuring leading experts addressing the most current and clinically relevant topics. Highlights include a keynote lecture on the Need for Diversity in Clinical Trials and the Healthcare Workforce, as well as sessions on MINOCA: Advances in Understanding and Management, Statins and Lp(a) Drugs: Whats New?, and Managing Menopause with Comorbidities: National Recommendations and New Drugs. Engaging debates will challenge participants to weigh the role of lifestyle modification versus GLP-1 receptor agonist therapy in weight management and to examine whether presentations of acute coronary syndrome (ACS) symptoms truly differ between women and men. Case-based sessions will provide practical insights into complex scenarios, including invasive evaluation of HFpEF, invasive coronary function testing, and management of hypertension in postmenopausal and pregnant women. The purpose of this symposium is to close the knowledge gaps of physicians and allied healthcare professionals regarding sex- and gender-specific differences in cardiovascular disease, the impact these differences have on treatment options, and the importance of identifying women at risk. The program will provide the most up-to-date evidence-based strategies for optimizing care for women with ischemic heart disease.

1. Apply current evidence to the diagnosis and management of MINOCA in women.
2. Evaluate the role of statins and emerging Lp(a)lowering therapies in lipid management for cardiovascular risk reduction.
3. Integrate national recommendations and new therapies in managing menopause with cardiovascular comorbidities.
4. Assess the benefits and limitations of lifestyle modification versus GLP1 receptor agonist therapy for weight management.
5. Differentiate presentations of acute coronary syndrome (ACS) symptoms in women versus men to improve diagnostic accuracy.
6. Demonstrate clinical decisionmaking through casebased learning, including invasive evaluation of HFpEF, invasive coronary function testing, and hypertension management in postmenopausal and pregnant women.

In-person Registration
In-person Healthcare Professionals: $125
In-person Residents/Fellows: $30

Virtual Registration
Virtual Healthcare Professionals: $175
Virtual Residents/Fellows: $40

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.

---

Hybrid Event (In-person and Virtual Attendees):

In-person Attendees-Before registering for this event, please read our Health and Safety Protocol for current requirements pertaining to attending in-person events. 

Virtual Attendees-By registering for the virtual activity, you will be able to view presentations, hear live audio, and interact online. This virtual activity will be fully web-based, and you will need a computer/laptop or tablet, audio and an internet connection. Details will be emailed to all attendees before the activity. Please be aware that you are not authorized to record, copy or share content in any manner.

Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

ANCC Credit for Nurses:  This activity is approved for 5.00 ANCC contact hours.

Interprofessional Continuing Education: This activity was planned by and for the healthcare team and learners will receive 5.00 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

MAINTENANCE OF CERTIFICATION (MOC) FOR PHYSICIANS: Successful completion of some CME activities, which includes participation in the evaluation component if required for the activity, may enable the participant to earn MOC points. As the CME activity provider, it is Cedars-Sinai’s responsibility to submit participant completion information to the ACCME for the purpose of granting earned MOC credit, provided the learner has completed the “Credit Reporting” steps indicated above in advance of the activity. If offered for this CME activity, MOC type and points that may be earned are indicated below.

American Board of Internal Medicine (ABIM) Part II MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AMA PRA Category 1 Credit(s)™ (MD, DO) (5.00 hours), ABIM MOC Part 2 (5.00 hours), ANCC (5.00 hours), IPCE (5.00 hours), Non-Physician AMA Attendance (5.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, April 17, 2026